Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bondo Hansen

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|February 16, 2006
Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectivesJohn Bondo Hansen
Diabetes|March 30, 2004
Improved beta-cell survival and reduced insulitis in a type 1 diabetic rat model after treatment with a beta-cell-selective K(ATP) channel openerKresten Skak, Carsten F Gotfredsen, Dorthe Lundsgaard, et al.
Diabetes|July 29, 2003
K(ATP) channels and pancreatic islet blood flow in anesthetized rats: increased blood flow induced by potassium channel openersLeif Jansson, Mikael Kullin, F Anders Karlsson, et al.
Experimental Neurology|August 21, 2022
Synergistic effect of serotonin 1A and serotonin 1B/D receptor agonists in the treatment of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned ratsMikael Thomsen, Anca Stoica, Kenneth Vielsted Christensen, et al.
International Journal of Antimicrobial Agents|September 19, 2003
Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureusGlenn W Kaatz, Varsha V Moudgal, Susan M Seo, et al.
British Journal of Pharmacology|January 29, 2005
Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channelsAnn Maria K Hansen, John Bondo Hansen, Richard D Carr, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2004
2-(4-Methoxyphenoxy)-5-nitro-N-(4-sulfamoylphenyl)benzamide activates Kir6.2/SUR1 K(ATP) channelsFlemming E Nielsen, Palle Jacobsen, Anne Worsaae, et al.
Journal of Medicinal Chemistry|April 12, 2007
Virtual screening for novel openers of pancreatic K(ATP) channelsEmanuele Carosati, Raimund Mannhold, Philip Wahl, et al.
Diabetes|May 29, 2002
The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel openerMichael Dabrowski, Frances M Ashcroft, Rebecca Ashfield, et al.
Bioorganic & Medicinal Chemistry Letters|September 13, 2017
Elucidation of antimicrobial activity and mechanism of action by N-substituted carbazole derivativesJohannes D Clausen, Lasse Kjellerup, Karen O'Hanlon Cohrt, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|February 16, 2006
Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectivesJohn Bondo Hansen
Diabetes|March 30, 2004
Improved beta-cell survival and reduced insulitis in a type 1 diabetic rat model after treatment with a beta-cell-selective K(ATP) channel openerKresten Skak, Carsten F Gotfredsen, Dorthe Lundsgaard, et al.
Diabetes|July 29, 2003
K(ATP) channels and pancreatic islet blood flow in anesthetized rats: increased blood flow induced by potassium channel openersLeif Jansson, Mikael Kullin, F Anders Karlsson, et al.
Experimental Neurology|August 21, 2022
Synergistic effect of serotonin 1A and serotonin 1B/D receptor agonists in the treatment of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned ratsMikael Thomsen, Anca Stoica, Kenneth Vielsted Christensen, et al.
International Journal of Antimicrobial Agents|September 19, 2003
Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureusGlenn W Kaatz, Varsha V Moudgal, Susan M Seo, et al.
British Journal of Pharmacology|January 29, 2005
Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channelsAnn Maria K Hansen, John Bondo Hansen, Richard D Carr, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2004
2-(4-Methoxyphenoxy)-5-nitro-N-(4-sulfamoylphenyl)benzamide activates Kir6.2/SUR1 K(ATP) channelsFlemming E Nielsen, Palle Jacobsen, Anne Worsaae, et al.
Journal of Medicinal Chemistry|April 12, 2007
Virtual screening for novel openers of pancreatic K(ATP) channelsEmanuele Carosati, Raimund Mannhold, Philip Wahl, et al.
Diabetes|May 29, 2002
The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel openerMichael Dabrowski, Frances M Ashcroft, Rebecca Ashfield, et al.
Bioorganic & Medicinal Chemistry Letters|September 13, 2017
Elucidation of antimicrobial activity and mechanism of action by N-substituted carbazole derivativesJohannes D Clausen, Lasse Kjellerup, Karen O'Hanlon Cohrt, et al.
Pageof 2